help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tomer, Y.
Right arrow Articles by Davies, T. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tomer, Y.
Right arrow Articles by Davies, T. F.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 4 1687-1693
Copyright © 2001 by The Endocrine Society


Original Studies

CTLA-4 and Not CD28 Is a Susceptibility Gene for Thyroid Autoantibody Production1

Yaron Tomer, David A. Greenberg, Giuseppe Barbesino, Erlinda Concepcion and Terry F. Davies

Division of Endocrinology and Metabolism, Departments of Medicine, Psychiatry (D.A.G.), and Biomathematics (D.A.G.), Mount Sinai School of Medicine, New York, New York 10029

Address all correspondence and requests for reprints to: Yaron Tomer, M.D., Division of Endocrinology and Metabolism, Box 1055, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, New York 10029. E-mail: yaron.tomer{at}mssm.edu

One of the hallmarks of the human autoimmune thyroid diseases (AITDs) is the production of high titers of autoantibodies against thyroglobulin and thyroid peroxidase that often precedes the development of clinical disease. A high percentage of family members of patients with AITDs have significant titers of thyroid antibodies (TAbs), suggesting a genetic predisposition for their development, and segregation analyses have favored a dominant mode of inheritance. The aim of the present study was to identify the susceptibility genes for TAb production. We completed a genome-wide scan in 56 multiplex families (323 individuals) in which all family members with AITDs and/or detectable TAbs were considered affected. The highest 2-point logarithm of odds (LOD) score of 3.6 was obtained for marker D2S325 on chromosome 2q33 at 210.9 centimorgans. This locus showed no evidence for linkage to Graves’ disease or Hashimoto’s thyroiditis (2-point LOD scores, 0.42 for Graves’ disease and -0.60 for Hashimoto’s thyroiditis), demonstrating that the gene in this region conferred susceptibility to TAbs, but that clinical disease development required additional genetic and/or environmental factors. We then fine-mapped the region linked with TAbs using 11 densely spaced microsatellite markers. Multipoint linkage analysis using these markers showed a maximum LOD score of 4.2 obtained for marker D2S155 at 209.8 centimorgans (with heterogeneity, {alpha} = 0.41). As the linked region contained the CTLA-4 and CD28 genes, we then tested whether they were the susceptibility genes for TAbs on chromosome 2q33. The CD28 gene was sequenced in 15 individuals, and a new C/T single nucleotide polymorphism (SNP) was identified in intron 3. Analysis of this SNP revealed no association with TAbs in the probands of the linked families (families that were linked with D2S155) compared with controls. The CTLA-4 gene was analyzed using the known A/G49 SNP, and the results showed a significantly increased frequency of the G allele in the probands of the linked families compared with the probands of the unlinked families or with controls (P = 0.02). We concluded that 1) a major gene for thyroid autoantibody production was located on chromosome 2q33; 2) the TAb gene on chromosome 2q33 was most likely the CTLA-4 gene and not the CD28 gene; and 3) CTLA-4 contributed to the genetic susceptibility to TAb production, but there was no evidence that it contributed specifically to Graves’ or Hashimoto’s diseases.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
J.-Y. Hsiao, M.-C. Hsieh, K.-J. Tien, S.-C. Hsu, S.-J. Shin, and S.-R. Lin
Association between a C/T Polymorphism in Exon 33 of the Thyroglobulin Gene Is Associated with Relapse of Graves' Hyperthyroidism after Antithyroid Withdrawal in Taiwanese
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3197 - 3201.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
B. MARASINI, P. A. FERRARI, N. SOLARO, and C. SELMI
Thyroid Dysfunction in Women with Systemic Sclerosis
Ann. N.Y. Acad. Sci., June 1, 2007; 1108(1): 305 - 311.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
P. S Hansen, T. H Brix, I. Iachine, K. O Kyvik, and L. Hegedus
The relative importance of genetic and environmental effects for the early stages of thyroid autoimmunity: a study of healthy Danish twins
Eur. J. Endocrinol., January 1, 2006; 154(1): 29 - 38.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Golden, L. Levin, Y. Ban, E. Concepcion, D. A. Greenberg, and Y. Tomer
Genetic Analysis of Families with Autoimmune Diabetes and Thyroiditis: Evidence for Common and Unique Genes
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4904 - 4911.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Ban, E. S. Concepcion, R. Villanueva, D. A. Greenberg, T. F. Davies, and Y. Tomer
Analysis of Immune Regulatory Genes in Familial and Sporadic Graves' Disease
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4562 - 4568.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P.-W. Wang, R.-T. Liu, S.-H. H. Juo, S.-T. Wang, Y.-H. Hu, C.-J. Hsieh, M.-H. Chen, I-Y. Chen, and C.-L. Wu
Cytotoxic T Lymphocyte-Associated Molecule-4 Polymorphism and Relapse of Graves' Hyperthyroidism after Antithyroid Withdrawal
J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 169 - 173.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Ban, D. A. Greenberg, E. Concepcion, L. Skrabanek, R. Villanueva, and Y. Tomer
Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease
PNAS, December 9, 2003; 100(25): 15119 - 15124.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
Y. Tomer and T. F. Davies
Searching for the Autoimmune Thyroid Disease Susceptibility Genes: From Gene Mapping to Gene Function
Endocr. Rev., October 1, 2003; 24(5): 694 - 717.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. E. Collins, J. M. Heward, J. Carr-Smith, J. Daykin, J. A. Franklyn, and S. C. L. Gough
Association of a Rare Thyroglobulin Gene Microsatellite Variant with Autoimmune Thyroid Disease
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 5039 - 5042.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Dittmar and G. J. Kahaly
Polyglandular Autoimmune Syndromes: Immunogenetics and Long-Term Follow-Up
J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 2983 - 2992.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. H. Kacem, A. Rebai, N. Kaffel, S. Masmoudi, M. Abid, and H. Ayadi
PDS Is a New Susceptibility Gene to Autoimmune Thyroid Diseases: Association and Linkage Study
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2274 - 2280.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Vaidya, P. Kendall-Taylor, and S. H. S. Pearce
The Genetics of Autoimmune Thyroid Disease
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5385 - 5397.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Anjos, A. Nguyen, H. Ounissi-Benkalha, M.-C. Tessier, and C. Polychronakos
A Common Autoimmunity Predisposing Signal Peptide Variant of the Cytotoxic T-lymphocyte Antigen 4 Results in Inefficient Glycosylation of the Susceptibility Allele
J. Biol. Chem., November 22, 2002; 277(48): 46478 - 46486.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society